Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates - Wang, Qidi; Zhang, Lianfeng; Kuwahara, Kazuhiko; Li, Li; Liu, Zijie; Li, Taisheng; Zhu, Hua; Liu, Jiangning; Xu, Yanfeng; Xie, Jing; Morioka, Hiroshi; Sakaguchi, Nobuo; et al. (ACS infectious diseases, 2016)
Keywords: Animals; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Antibody-Dependent Enhancement; Disease Models, Animal; Epitopes, B-Lymphocyte - chemistry; Epitopes, B-Lymphocyte - immunology; Humans; Immunodominant Epitopes - chemistry; Immunodominant Epitopes - genetics; Immunodominant Epitopes - immunology; Macaca mulatta; SARS Virus - chemistry; SARS Virus - genetics; SARS Virus - immunology; Severe Acute Respiratory Syndrome - immunology; Severe Acute Respiratory Syndrome - virology; Spike Glycoprotein, Coronavirus - chemistry; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; peptide; vaccine; antibody-dependent enhancement (ADE); epitope sequence-dependent (ESD) enhancement; B-cell peptide epitope; SARS-CoV